https://www.polity.org.za
Deepening Democracy through Access to Information
Home / News / All News RSS ← Back
Africa|Manufacturing|Manufacturing
Africa|Manufacturing|Manufacturing
africa|manufacturing|manufacturing-industry-term
Close

Email this article

separate emails by commas, maximum limit of 4 addresses

Sponsored by

Close

Article Enquiry

Bavarian Nordic sees potential to ramp up mpox vaccine capacity

Close

Embed Video

Bavarian Nordic sees potential to ramp up mpox vaccine capacity

Mpox virus test tubes
Photo by Reuters

12th September 2024

By: Reuters

SAVE THIS ARTICLE      EMAIL THIS ARTICLE

Font size: -+

Bavarian Nordic said on Thursday it could supply 13-million doses of its mpox vaccine by the end of 2025, up from a previous forecast of 10-million doses, and is exploring options to significantly expand its capacity.

The Danish biotech company said it had also identified measures that could boost supply by a further 50-million doses within the next 12 to 18 months, subject to regulatory approvals and market demand.

Advertisement

"It depends first and foremost on demand. If the demand is there and the other conditions are in place, we have the opportunity to increase by another 50-million doses," Bavarian's head of investor relations Rolf Sass Sorensen said.

The World Health Organization declared mpox a global health emergency last month but efforts to curb the spread of the disease have been hampered by a lack of vaccines.

Advertisement

Sorensen said supply also hinges on ongoing discussions about collaborations with partners in Africa and elsewhere regarding the transfer of manufacturing, alongside the adoption of other methods and technologies with a higher yield.

"It could perhaps be that you get help to make fill-and-finish," Sorensen said.

Bavarian said certain existing orders for mpox vaccines based on contracts with the US government would be pushed back to 2025 from 2024 in order to meet other market needs.

The Democratic Republic of Congo, the epicentre of the latest mpox outbreak, received its first batch of mpox vaccines last week.

EMAIL THIS ARTICLE      SAVE THIS ARTICLE

To subscribe email subscriptions@creamermedia.co.za or click here
To advertise email advertising@creamermedia.co.za or click here

Comment Guidelines

About

Polity.org.za is a product of Creamer Media.
www.creamermedia.co.za

Other Creamer Media Products include:
Engineering News
Mining Weekly
Research Channel Africa

Read more

Subscriptions

We offer a variety of subscriptions to our Magazine, Website, PDF Reports and our photo library.

Subscriptions are available via the Creamer Media Store.

View store

Advertise

Advertising on Polity.org.za is an effective way to build and consolidate a company's profile among clients and prospective clients. Email advertising@creamermedia.co.za

View options

Email Registration Success

Thank you, you have successfully subscribed to one or more of Creamer Media’s email newsletters. You should start receiving the email newsletters in due course.

Our email newsletters may land in your junk or spam folder. To prevent this, kindly add newsletters@creamermedia.co.za to your address book or safe sender list. If you experience any issues with the receipt of our email newsletters, please email subscriptions@creamermedia.co.za